Ciglitazone is a potent and selective PPARgamma agonist (EC50=3 µM). Ciglitazone inhibits proliferation and differentiation of th17 cells. Ciglitazone is a hypoglycemic agent orally active in the obese-hyperglycemic animal models. Ciglitazone induces apoptosis accompanied by activation of p38 MAPK and nuclear translocation of apoptosis inducing factor (AIF) in opossum kidney (OK) renal epithelial cells[1][2][3][4].
Molekulargewicht:
333.45
Reinheit:
99.74
CAS Nummer:
[74772-77-3]
Formel:
C18H23NO3S
Target-Kategorie:
PPAR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
